Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
Maintaining your bone health is central to preventing myeloma. According to the study linked and excerpted below, blood levels of vitamin D3 are an important predictor of multiple myeloma. My experience and research indicates that vitamin D3 supplementation is an important multiple myeloma bone health therapy as well.
I began supplementing with Vitamin D3 years ago. Being a survivor a multiple myeloma (incurable blood cancer) I decided that I should take Vitamin D3 daily to enhance my bone health. I supplement with Life Extension Vitamin D3 (1000mg x 2 daily).
According to ConsumerLabs.com optimal blood levels of Vitamin D3 may prevent cancer, enhance bone health, reduce the risk of Parkinson’s, rheumatoid arthritis, heart attacks, diabetes, hypertension, reduce symptoms of fibromyalgia, reduce the risk uterine fibroids, Alzheimer’s disease, dementia, depression, and other conditions.
Why do I supplement with LEF Vitamin D3?
“Conclusion: Vitamin D levels are frequently low among multiple myeloma patients and, despite this, screening levels of this vitamin is not thought to be part of the routine work up by the vast majority of oncologists in the United States.”
“Most people do not think about their vitamin D intake, but Chloe Spear, BSN, RN, OCN, knows that it is important – especially for patients with myeloma.
Spear, clinical specialty coordinator in the Myeloma Program at Mount Sinai, conducted a study examining the effects that a vitamin D deficiency can have on outcomes for patients with myeloma. She hopes to turn her findings – that patients with deficiencies have poorer prognoses – into a standard-of-care for treating patients who come into the clinic with vitamin D deficiencies. Intervention would be fairly simple and straightforward: prescribing patients with oral vitamin D supplements to take daily.”
“We found a widespread and alarming rate of vitamin D deficiency in patients with metastatic bone disease and multiple myeloma. Of note, patients with bone metastases due to breast cancer, prostate cancer and multiple myeloma rarely reached sufficient serum 25-OH-D levels.
Conclusion: It is of utmost clinical importance to assess vitamin D levels in cancer patients, especially in those with, or at high risk of developing metastatic bone disease…
In summary, the present study highlights a widespread and alarming rate of vitamin D deficiency in patients with metastatic bone disease and multiple myeloma.
Of note, patients with bone metastases due to breast cancer, prostate cancer and multiple myeloma rarely reached sufficient serum 25-OH-D levels and yet vitamin D deficiency often goes unrecognised and therefore remains untreated. Hence, it is of utmost clinical importance to assess vitamin D levels in cancer patients, especially those with, or at high risk of developing metastatic bone disease. Bone health.